170 related articles for article (PubMed ID: 31703092)
1. Perception of potential harm and benefits of HIV vaccine trial participation: A qualitative study from urban Tanzania.
Tarimo EAM; Ambikile J; Munseri P; Bakari M
PLoS One; 2019; 14(11):e0224831. PubMed ID: 31703092
[TBL] [Abstract][Full Text] [Related]
2. Gender aspects on HIV prevention efforts and participation in HIV vaccine trials among Police officers in Dar es Salaam, Tanzania.
Tarimo EAM; Kakoko DCV; Kohi TW; Bakari M; Sandstrom E; Siyame D; Mhalu F; Kulane A
BMC Public Health; 2018 Jul; 18(1):905. PubMed ID: 30031376
[TBL] [Abstract][Full Text] [Related]
3. Sexual Behaviours and Practices before and after Phase I/II HIV Vaccine Trial: A Qualitative Study among Volunteers in Dar es Salaam Tanzania.
Iseselo MK; Tarimo EAM; Sandstrom E; Kulane A
Int J Environ Res Public Health; 2020 Oct; 17(19):. PubMed ID: 33019597
[TBL] [Abstract][Full Text] [Related]
4. Balancing collective responsibility, individual opportunities and risks: a qualitative study on how police officers reason around volunteering in an HIV vaccine trial in Dar es Salaam, Tanzania.
Tarimo EA; Thorson A; Kohi TW; Mwami J; Bakari M; Sandström E; Kulane A
BMC Public Health; 2010 May; 10():292. PubMed ID: 20509908
[TBL] [Abstract][Full Text] [Related]
5. Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania.
Tarimo EA; Munseri P; Aboud S; Bakari M; Mhalu F; Sandstrom E
PLoS One; 2014; 9(3):e90938. PubMed ID: 24603848
[TBL] [Abstract][Full Text] [Related]
6. Personal experiences following acquiring HIV infection while volunteering in Phase I/II HIV vaccine trials: A qualitative study from Tanzania.
Tarimo EAM; Ambikile J; Munseri P; Bakari M
PLoS One; 2022; 17(10):e0276404. PubMed ID: 36288332
[TBL] [Abstract][Full Text] [Related]
7. Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trial.
Bakari M; Munseri P; Francis J; Aris E; Moshiro C; Siyame D; Janabi M; Ngatoluwa M; Aboud S; Lyamuya E; Sandström E; Mhalu F
BMC Public Health; 2013 Dec; 13():1149. PubMed ID: 24321091
[TBL] [Abstract][Full Text] [Related]
8. Motivations to participate in a Phase I/II HIV vaccine trial: A descriptive study from Dar es Salaam, Tanzania.
Tarimo EA; Bakari M; Kakoko DC; Kohi TW; Mhalu F; Sandstrom E; Kulane A
BMC Public Health; 2016 Feb; 16():182. PubMed ID: 26911203
[TBL] [Abstract][Full Text] [Related]
9. Comprehension of informed consent and voluntary participation in registration cohorts for phase IIb HIV vaccine trial in Dar Es Salaam, Tanzania: a qualitative descriptive study.
Iseselo MK; Tarimo EAM
BMC Med Ethics; 2024 Mar; 25(1):29. PubMed ID: 38481301
[TBL] [Abstract][Full Text] [Related]
10. Factors that influence the willingness of young adults in Dar es Salaam, Tanzania, to participate in phase I/II HIV vaccine trials.
Mbunda T; Bakari M; Tarimo EA; Sandstrom E; Kulane A
Glob Health Action; 2014; 7():22853. PubMed ID: 24572007
[TBL] [Abstract][Full Text] [Related]
11. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
[TBL] [Abstract][Full Text] [Related]
12. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
[TBL] [Abstract][Full Text] [Related]
13. A qualitative evaluation of volunteers' experiences in a phase I/II HIV vaccine trial in Tanzania.
Tarimo EA; Thorson A; Kohi TW; Bakari M; Sandstrom E; Mhalu F; Kulane A
BMC Infect Dis; 2011 Oct; 11():283. PubMed ID: 22023776
[TBL] [Abstract][Full Text] [Related]
14. Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania.
Tarimo EA; Thorson A; Kohi TW; Bakari M; Mhalu F; Kulane A
PLoS One; 2011 Feb; 6(2):e14619. PubMed ID: 21358826
[TBL] [Abstract][Full Text] [Related]
15. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.
Chakrapani V; Newman PA; Singhal N; Jerajani J; Shunmugam M
PLoS One; 2012; 7(12):e51080. PubMed ID: 23226560
[TBL] [Abstract][Full Text] [Related]
16. The perceptions on male circumcision as a preventive measure against HIV infection and considerations in scaling up of the services: a qualitative study among police officers in Dar es Salaam, Tanzania.
Tarimo EA; Francis JM; Kakoko D; Munseri P; Bakari M; Sandstrom E
BMC Public Health; 2012 Jul; 12():529. PubMed ID: 22812484
[TBL] [Abstract][Full Text] [Related]
17. Willingness to Participate in Hypothetical HIV Vaccine Trial and Associated Factors among People Who Inject Drugs in Dar es Salaam, Tanzania.
Iseselo MK; Tarimo EAM; Sandstrom E; Kulane A
Biomed Res Int; 2020; 2020():8507981. PubMed ID: 32714988
[TBL] [Abstract][Full Text] [Related]
18. "If It's Not Working, Why Would They Be Testing It?": mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India.
Chakrapani V; Newman PA; Singhal N; Nelson R; Shunmugam M
BMC Public Health; 2013 Aug; 13():731. PubMed ID: 23919283
[TBL] [Abstract][Full Text] [Related]
19. What motivates or demotivates injecting drug users to participate in hypothetical HIV vaccine efficacy trials? A qualitative study from urban Tanzania.
Iseselo MK; Tarimo EA; Sandstrom E; Kulane A
East Afr Health Res J; 2020; 4(2):128-139. PubMed ID: 34308230
[TBL] [Abstract][Full Text] [Related]
20. Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.
Strauss RP; Sengupta S; Kegeles S; McLellan E; Metzger D; Eyre S; Khanani F; Emrick CB; MacQueen KM
J Acquir Immune Defic Syndr; 2001 Jan; 26(1):63-71. PubMed ID: 11176270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
